Finance

Lists
SOPH:NASDAQ
Sophia Genetics SA
8,30 USD
+0,24%
(+0,020) 1D
8,30 USD
0,00% (0,00)
After hours
Closed: 3-сен., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOPH...
Open
8,30 USD
High
8,36 USD
Low
7,93 USD
Mkt. cap
706,56 млн
Avg. vol.
506,64 миң
Volume
698,27 миң
52-wk high
8,98 USD
52-wk low
3,10 USD
EPS
-1,15 USD
Beta
0,98
Shares outstanding
85,13 млн
No. of employees
415
Open
8,30 USD
High
8,36 USD
Low
7,93 USD
Mkt. cap
706,56 млн
Avg. vol.
506,64 миң
Volume
698,27 миң
52-wk high
8,98 USD
52-wk low
3,10 USD
EPS
-1,15 USD
Beta
0,98
Shares outstanding
85,13 млн
No. of employees
415
Profile
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions. Wikipedia
About Sophia Genetics SA
CEOJurgi Camblong
Employees415
Founded2011-ж., 1-янв.
Headquarters-
SectorHealth care
Analyst ratings
Based on 5 analysts giving stock ratings to SOPH in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SOPH in the last 3 months.
Highest
Current 8,30 USD
14,00 USD (+68,67%)
Average
10,00 USD (+20,48%)
Lowest
7,00 USD (-15,66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
14,00 USD
+68,7%
08/31/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
7,00 USD
-15,7%
08/04/2026
Mark Massaro
BTIG
Buy
Reiterated
9,00 USD
+8,4%
08/05/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
08/04/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
06/08/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
7,00 USD
-15,7%
05/06/2026
Last report
2026-ж., 4-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,20 USD / -0,22 USD
+10,95%beat
Revenue / Est. (USD)
23,31 млн / 21,71 млн
+7,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
19,46 млн
21,71 млн
21,69 млн
23,31 млн
Cost of goods sold
6,56 млн
7,02 млн
6,94 млн
8,25 млн
Cost of revenue
6,56 млн
7,02 млн
6,94 млн
8,25 млн
Research and development expenses
8,07 млн
8,54 млн
9,46 млн
8,73 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,56 млн
24,65 млн
22,57 млн
26,39 млн
Operating expense
30,77 млн
33,24 млн
32,03 млн
35,11 млн
Total operating expenses
37,32 млн
40,25 млн
38,97 млн
43,36 млн
Operating income
-17,86 млн
-18,54 млн
-17,28 млн
-20,05 млн
Other non operating income
-607,00 миң
90,00 миң
-92,00 миң
-317,00 миң
EBT including unusual items
-19,38 млн
-19,57 млн
-19,07 млн
-22,28 млн
EBT excluding unusual items
-19,38 млн
-19,60 млн
-19,07 млн
-22,28 млн
Income tax expense
642,00 миң
-395,00 миң
253,00 миң
78,00 миң
Effective tax rate
-3,31%
2,02%
-1,33%
-0,35%
Other operating expenses
143,00 миң
45,00 миң
-
-5,00 миң
Net income
-20,02 млн
-19,18 млн
-19,32 млн
-22,36 млн
Net profit margin
-102,87%
-88,35%
-89,09%
-95,91%
Earnings per share
-0,20
-0,17
-0,19
-0,20
Interest and investment income
622,00 миң
381,00 миң
289,00 миң
231,00 миң
Interest expense
-1,66 млн
-1,67 млн
-1,67 млн
-1,62 млн
Net interest expenses
-1,04 млн
-1,29 млн
-1,38 млн
-1,39 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,77 млн
-18,10 млн
-16,13 млн
-18,90 млн
Gain or loss from assets sale
-
-
3,00 миң
-3,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору